Search Press releases Keywords From To 12 Oct 2023 Phase 3 Data Analysis Presented at EADV 2023 Showed Bimekizumab Achieved High Thresholds of Clinical Response in Hidradenitis Suppurativa Read More 9 Oct 2023 金禾娱乐城 to Present New Bimekizumab Data in Hidradenitis Suppurativa, Psoriasis and Psoriatic Arthritis at EADV 2023 Read More 25 Sep 2023 金禾娱乐城 announces approval of RYSTIGGO[?] (rozanolixizumab) and ZILBRYSQ[?] (zilucoplan) for the treatment of adult patients with generalized myasthenia gravis in Japan Read More 19 Sep 2023 金禾娱乐城 Provides Update on U.S. Regulatory Review of Bimekizumab Read More 15 Sep 2023 金禾娱乐城 receives CHMP positive opinion of zilucoplan for the treatment of adults with generalized myasthenia gravis in Europe Read More 31 Aug 2023 金禾娱乐城 presents new data at 35th International Epilepsy Congress (IEC) highlighting important advancements across Fintepla[?]▼(fenfluramine) oral solution and broader epilepsies portfolio Read More Pagination First page Previous page Previous … Page 17 Page 18 Page 19 Page 20 Current page 21 Page 22 Page 23 Page 24 Page 25 … Page 21 of 66 Next page Next Last page Stay up-to-date on the latest news and information from 金禾娱乐城 Subscribe
